Search

Date 2016 Author/Creator Harding, J.

1. Detection of IDH1 mutations in circulating free DNA in patients with cholangiocarcinoma. (December 2016)

Authors:
Lowery, M.A.; You, D.; Samoila, A.; Peerschke, E.; Viale, A.; Patel, R.; Selcuklu, D.; Rusek, M.; Cercek, A.; Kemeny, N.; Harding, J.; Mellinghoff, I.; Tap, W.; Abou-Alfa, G.K.; Moynahan, M.
Journal:
European journal of cancer
Issue:
Volume 69(2016)supplement 1
Page Start:
S141
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase 1 study of CB-839, a small molecule inhibitor of glutaminase, in combination with everolimus in patients (pts) with clear cell and papillary renal cell cancer (RCC). (December 2016)

Authors:
Meric-Bernstam, F.; Tannir, N.; Harding, J.; Voss, M.; Mier, J.; DeMichele, A.; Munster, P.; Patel, M.; Iliopoulos, O.; Owonikoko, T.; Whiting, S.; Orford, K.; Bennett, M.; Carvajal, R.; McKay, R.; Fan, A.; Telli, M.; Infante, J.
Journal:
European journal of cancer
Issue:
Volume 69(2016)supplement 1
Page Start:
S12
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search